Catalent, Inc., a global provider of delivery technologies and development services for pharma/biopharma and consumer health products, has agreed to acquire Accucaps Industries Ltd., a Canadian-based developer and manufacturer of OTC, high potency and conventional pharmaceutical softgels. Financial details were not disclosed.   The acquisition expands Catalent’s global OTC and prescription pharmaceutical softgel capabilities and capacity with the addition of a portfolio of pharmaceutical produ...